Factors associated with knowledge, attitudes, and behaviors regarding antiviral medications for COVID-19 among US adults

E. Ivy Oyegun, Muyiwa Ategbole, Cynthia Jorgensen, Allison Fisher, Melissa Briggs Hagen, Lindsay Gutekunst, Eric Roberts, Emilia H. Koumans
doi: https://doi.org/10.1101/2023.12.11.23299148

Article Information

doi 
https://doi.org/10.1101/2023.12.11.23299148
History 
  • February 11, 2024.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. E. Ivy Oyegun, MPH1,*,
  2. Muyiwa Ategbole, MD2,
  3. Cynthia Jorgensen, DrPH3,
  4. Allison Fisher, MPH1,
  5. Melissa Briggs Hagen, MD1,
  6. Lindsay Gutekunst, MA4,
  7. Eric Roberts, BA4 and
  8. Emilia H. Koumans, MD1
  1. 1Centers for Disease Control and Prevention
  2. 2Tanaq Support Services
  3. 3Emory University Rollins School of Public Health
  4. 4KRC Research
  1. ↵*Corresponding Author:
    E. Ivy Oyegun, MPH, Epidemiology Branch, Coronavirus and Other Respiratory Viruses Division (CORVD), National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Phone: 1.404.639.4091, wvw2{at}cdc.gov
Back to top
Posted February 11, 2024.
Download PDF
Data/Code
Email
Factors associated with knowledge, attitudes, and behaviors regarding antiviral medications for COVID-19 among US adults
E. Ivy Oyegun, Muyiwa Ategbole, Cynthia Jorgensen, Allison Fisher, Melissa Briggs Hagen, Lindsay Gutekunst, Eric Roberts, Emilia H. Koumans
medRxiv 2023.12.11.23299148; doi: https://doi.org/10.1101/2023.12.11.23299148
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area